Convening Period Extended to 27 January 2027
Filed with ASX · · 2 pages · English
Summary by 6ix AI
This extension was approved by the Supreme Court of Western Australia and allows the administrators to address outstanding matters before the meeting. The administrators anticipate being able to issue the Voluntary Administrators’ Report and convene the meeting sooner than the extended deadline.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Paradigm Biopharmaceuticals Ltd. on 6ix
Earlier from Paradigm Biopharmaceuticals
- Deferral of AGM and Financial Reporting Obligations
- Extension of Convening Period
- Notification of cessation of securities - PAR
- Further Agreed Convertible Note Redemption
- PPS Shows Significant Pain Benefit in Rest of World Analysis
Later from Paradigm Biopharmaceuticals
All Paradigm Biopharmaceuticals news releasesFollow Paradigm Biopharmaceuticals into a list and get an email when it puts out news.
Follow Paradigm Biopharmaceuticals